Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Dimethyl fumarate inhibits the expression and function of hypoxia-inducible factor-1α (HIF-1α).
Efficacy and Safety of Fingolimod in Hispanic Patients with Multiple Sclerosis: Pooled Clinical Trial Analyses.
Rapid exacerbation of multiple sclerosis following the initiation of interferon-β: report of nine cases.
Improvements in cognition, quality of life, and physical performance with clinical Pilates in multiple sclerosis: a randomized controlled trial.
Myelin in cartilaginous fish.
Burden of neurological conditions in Canada.
Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility.
Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis.
Dimethyl fumarate attenuates cerebral edema formation by protecting the blood-brain barrier integrity.
Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases.
Tolerability and pharmacokinetics of delayed-release dimethyl fumarate administered with and without aspirin in healthy volunteers.
Standing up in multiple sclerosis (SUMS): protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis.
Glatiramer acetate induced hepatotoxicity.
Leisure time activities of Iranian patients with multiple sclerosis: a qualitative study.
Alkali metals levels in the human brain tissue: Anatomical region differences and age-related changes.
Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosis.
A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation.
Demyelination induces transport of ribosome-containing vesicles from glia to axons: evidence from animal models and MS patient brains.
Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression.
CLIPPERS complicating multiple sclerosis causing concerns of CNS lymphoma.
Evidence for Mitoxantrone-induced Block of Inwardly Rectifying K Channels Expressed in the Osteoclast Precursor RAW 264.7 Cells Differentiated with Lipopolysaccharide.
The absence of 25-hydroxyvitamin D3-1α-hydroxylase potentiates the suppression of EAE in mice by ultraviolet light.
The nature of genetic susceptibility to multiple sclerosis: constraining the possibilities.
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.
UCSF Seminar: "The needle in the haystack: Searching for target antigens of the adaptive immune response in MS."
Pages
« first
‹ previous
…
78
79
80
81
82
83
84
85
86
…
next ›
last »